| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |